期刊文献+

两种不同血液净化方式对血清钙磷及甲状旁腺激素清除的对比研究 被引量:2

Comparative study of influences of two different blood purification treatments on clearance of serum calcium,phosphorus and parathyroid hormone
下载PDF
导出
摘要 目的:探讨血液灌流串联血液透析(HP+HD)与血液透析滤过(HDF)对尿毒症患者血清中钙(Ca2+)、磷(P3+)、甲状旁腺激素(PTH)清除的效果。方法:选择长期维持并规律性进行血液透析的尿毒症患者40例,随机分为HP+HD组20例,每2 w常规血液透析(HD)治疗5次,HP+HD治疗1次;HDF组20例,每2 w常规血液透析(HD)治疗5次,HDF治疗1次。两组疗程均为12 w。分别记录首次透析前后及治疗4、12 w时血清Ca2+、P3+、PTH值,并对两组进行比较。结果:两组均可使血清Ca2+、P3+、PTH值下降。首次治疗清除效果均显著(P<0.01);治疗4、12 w时,血清Ca2+、P3+的下降不及PTH下降明显,但HP+HD组较HDF组清除血清Ca2+、P3+明显(P<0.05),清除PTH更明显(P<0.01)。结论:HP+HD能有效地清除尿毒症患者血清中的Ca2+、P3+和PTH,且优于HDF,有临床推广价值。 Objective:To investigate the clearance effects of hemodiafiltration (HDF) and hemoperfusion combined with hemodialysis ( HP + HD) on serum calcium ( Ca^2+ ) , phosphorus ( p3 + ) , parathyroid hormone ( PTH ) in uremic patients. Methods: 40 cases of uremia receiving regularly tong - term maintenance hemedialysis were randomly divided into two groups ( n = 20). Every two weeks, patients in HP + HD group underwent HD conventional treatment 5 times and HP + HD treatment once every, two weeks, while those in HDF group underwent HD treatment 5 times and HDF treatment also once every two weeks. All of them were treated for 12 weeks. The levels of serum Ca^2+、P^3+ , PTH ( by chemiluminescence determination) were recorded and compared between the two groups. Results: The levels of serum Ca^2+、P^3+ , PTH decreased and the clearance effects of the first time were significant in both groups compared with those before treatment( P 〈0. 01 ). But the decline amplitude of serum Ca^2+、P^3+ at the 4th and 12th week was less than that of PTH. Moreover, serum Ca^2+、P^3+ in HP + HD group were removed more markedly and PTH clearance in HP + HD group was more evident than those in HDF group( P 〈 0. 01 - 0.05 ). Conclusion: HP combined with HD can efficiently remove the serumCa^2+、P^3+ and PTH in uremic patients and its clearance effect is better than HDF. This method is worthy to be promoted in clinical practice.
出处 《西南国防医药》 CAS 2009年第12期1197-1199,共3页 Medical Journal of National Defending Forces in Southwest China
关键词 血液灌流 血液透析 血液透析滤过 尿毒症 hemoperfusion hemodialysis hemodiafiltration uremia
  • 相关文献

参考文献5

二级参考文献14

  • 1[1]Sato T, Shoji H, Koga N. Endotoxin adsorption by polymyxin B immo bileized fiber column in patients with systemic inflammatory rssponse syndrome: The Japanese Experiense, Therapeutic Apheresis and Dialysis,2003,7(2) :252 - 258
  • 2[2]Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis:Endotoxin adsorption cartridge(Toraymyxin). Therapeutic Apheresis and Dialysis, 2003,7(1):108 - 114
  • 3[3]Schmaldienst S, Banyai S, Stulnig TM, et al. Prospective randomised cross- over comparison of three LDL - apheresis system in stain pretreated patients with familial hypercholesterolaemia. Athernsclerosis,2000,151(2) :493 - 7
  • 4[4]Ritter M. M, Parhofer K.G. Extracorporal low - density lipoprotein by innunoadsorption. Therapeutic Apheresis and Dialysis, 2003, 7 ( 3 ):370 - 372
  • 5[5]Nakaji S, Haynshi N. Adsorption for myasthenia gravis treatment:Medisorba MG - 50. Therapeutic Apheresis and dialysis, 2003,7 ( 1 ):78 - 84
  • 6[6]Hirata N, Kuriyama T, Yamawaki N. Immusorba TR and PH. Therapeutic Apheresis and Dialysis, 2003,7( 1 ) :85 - 90
  • 7[7]Bambauer R,Schiel R, Latza R,et al. LDL apheresis in clinical practice: long - term treatment of severe hyperlipidemia. Ther Apher, 1997,1(1): 49-51
  • 8[8]Brunton C, Varghese Z, Moorhead F. Lipoheresis in the nephrotic syndrome. kidney Int,1999,56(Suppl 71) :s6- s8
  • 9[9]Yamamoto T,Yammashita T. Low - density lioprotein apheresis using the liposorber system: feature and clinical benefits. Ther Apher, 1998, 2(1) :25- 30
  • 10[10]Bosch T, Keller C. Clinical effect of direct adorption of lipoprotein apheresis: Beyond cholesterol reduction. Therapeutic Apheresis and Dialysis, 2003, 7(3) :341 - 344

共引文献36

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部